口腔下纤维化:病原和治疗方法
Jianfei Tang1, Junjie Liu1, Zekun Zhou1
1Hunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University, Changsha, China.
口腔膜纤维化 (OSF) 是一种进展性疾病,导致口腔组织硬化和潜在的癌症. 了解其复杂的机制是开发向抗纤维菌疗法的关键.
科学领域:
- 口腔病理学 口腔病理学
- 纤维化研究纤维化.
- 在瘤学瘤学.
背景情况:
- 口腔膜纤维化 (OSF) 是口腔粘膜的一个慢性,渐进的纤维性疾病.
- 它的特点是细胞外基质 (ECM) 沉积过多,导致组织硬化和潜在的恶性转变.
- 目前对OSF的抗纤维菌策略是有限的,因为不完全理解病原性机制.
研究的目的:
- 审查OSF的流行病学和病因学.
- 阐明驱动OSF病变的细胞和免疫机制.
- 总结潜在的治疗策略,针对关键的纤维化通路.
主要方法:
- 本综述综合了有关OSF的当前文献.
- 它检查了结构细胞中细胞内在的变化,这些变化有助于肌纤维细胞激活.
- 它讨论了先天性和适应性免疫细胞在OSF病变发生中的作用.
主要成果:
- 结构细胞的细胞内在变化显著驱动纤维化反应.
- 肌纤维细胞激活和ECM的产生是OSF的核心.
- 天生的和适应性免疫细胞在疾病的进展中起着至关重要的作用.
结论:
- 针对ECM调节,炎症抑制和血管干扰是有希望的治疗途径.
- 对OSF机制的进一步研究可以指导新型抗纤维治疗方法的开发.
- 这一审查为开发有效的抗OSF治疗方法提供了基础.
更多相关视频
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
05:57ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection
Published on: February 10, 2017
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
